test cancer API Toggle ON

Recruiting
All
Phase N/A
1 Location

Brief description of study

See protocol section 2 See protocol section 2 See protocol section 2.

this is p tag.

header

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Gender: All

Inclusion Criteria:

  1. Pathologically confirmed invasive breast cancer
  2. Stage IIB-III invasive breast cancer (AJCC 8th edition)
  3. Patients planned for adjuvant chemotherapy and adjuvant radiotherapy
  4. Patients fit to receive adjuvant chemotherapy and radiotherapy
  5. Age > 18 years

Exclusion Criteria:

  1. Hypersensitivity to taxanes
  2. Patients receiving entire chemotherapy prior to surgery (neoadjuvant setting)
  3. Unable or unwilling for regular follow up
  4. Bilateral tumour needed RT to both sides
  5. Patients planned for RT to oligometastatic sites
  6. Unfavourable anatomical factors potentially leading to higher radiotherapy dose to heart and/or lungs (Exceeding the protocol specific mandatory dose constraints).
  7. Pregnant patient

Updated on 10 Mar 2026. Study ID: NCT776T2977

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.